Druce, Katie L.Bhattacharya, YagnaseniJones, Gareth T.Macfarlane, Gary J.Basu, Neil2017-06-212017-06-212016-10Druce, K L, Bhattacharya, Y, Jones, G T, Macfarlane, G J & Basu, N 2016, 'Most patients who reach disease remission following anti-TNF therapy continue to report fatigue : results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis', Rheumatology, vol. 55, no. 10, pp. 1786-1790. https://doi.org/10.1093/rheumatology/kew2411462-0324ORCID: /0000-0003-2322-3314/work/29064667ORCID: /0000-0003-0016-7591/work/83703948http://hdl.handle.net/2164/8848Acknowledgements K.L.D. was funded by a studentship from the Institute of Applied Health Sciences, University of Aberdeen. Y.B. was funded by a studentship from the Aberdeen Summer Research Studentship Programme, University of Aberdeen. The BSR commissioned the BSRBR-RA as a UK-wide national project to investigate the safety of biologic agents in routine medical practice. BSR receives restricted income from UK pharmaceutical companies, including Abbott Laboratories, Merck, Pfizer, Roche, UCB and SOBI. This income finances a wholly separate contract between the BSR and the University of Manchester, who provide and oversee the BSRBR-RA data collection, management and analysis service. The principal investigators and their team have full academic freedom and are able to work independently of pharmaceutical industry influence. All decisions concerning analyses, interpretation and publication are made autonomously of any industry contributions. Funding: No specific funding was received from any bodies in the public, commercial or not-for-profit sectors to carry out the work described in this article. Disclosure statement: The authors have declared no conflicts of interest.552948engfatiguedisease activityremissionR MedicineRJournal article10.1093/rheumatology/kew2415510